Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of using IL-29 cysteine mutant to treat hepatitis C and hepatitis B

Method of using IL-29 cysteine mutant to treat hepatitis C and hepatitis B

US Patent 7727518 · Granted Jun 1, 2010

Estimated economic value: $4,705,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies modified for transglutaminase conjugation, conjugates thereof, and me2025
Antibodies against TIM3 and uses thereof2025
Antibody comprising a glutamine-containing light chain C-terminal extension, con2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
Antibodies binding to VISTA at acidic pH2025
Antibodies binding to vista at acidic pH2024
Antibodies to mucin-16 (MUC16), encoding polynucleotides and methods of treating2024
Antibodies against TIM3 and uses thereof2024
Antibodies binding to vista at acidic pH2024
Antibodies to TIGIT2024
Constructs targeting prostate-specific membrane antigen (PSMA) and uses thereof2024